Page 2 - Technogene Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recombinant Proteins Market Research Report by Product (Adhesion Molecules and Receptors, Growth Factors and Chemokines, and Immune Response Proteins),...

Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities

Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities

Share this article Share this article ResearchAndMarkets.com's offering. The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors ex...

The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market. In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on product, the recombinant proteins market is classified into growth factors and chemokines, structural proteins, kinase proteins, regulatory proteins, membrane proteins, recombinant m...